Third Rock, Take­da-backed Am­bys ush­ers in ex-NGM Bio pres­i­dent Jeff Jonker as CEO

Trained as a lawyer, Jeff Jonker has a lot in com­mon with Mer­ck’s Ken Fra­zier, who was in charge of de­fend­ing Mer­ck’s con­tro­ver­sial Vioxx in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.